APA (7th ed.) Citation

LR, P., F, W., PP, C., D, O., G, M., & SM, A. (2022). Preclinical efficacy and safety of novel SNAT against SARS-CoV-2 using a hamster model. Drug delivery and translational research, 12(12), 3007. https://doi.org/10.1007/s13346-022-01166-x

Chicago Style (17th ed.) Citation

LR, Pokhrel, Williams F, Cook PP, O'Rourke D, Murray G, and Akula SM. "Preclinical Efficacy and Safety of Novel SNAT Against SARS-CoV-2 Using a Hamster Model." Drug Delivery and Translational Research 12, no. 12 (2022): 3007. https://doi.org/10.1007/s13346-022-01166-x.

MLA (9th ed.) Citation

LR, Pokhrel, et al. "Preclinical Efficacy and Safety of Novel SNAT Against SARS-CoV-2 Using a Hamster Model." Drug Delivery and Translational Research, vol. 12, no. 12, 2022, p. 3007, https://doi.org/10.1007/s13346-022-01166-x.